Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating auricular point stimulation plus dexamethasone to prevent chemotherapy-induced nausea and vomiting from gemcitabine plus paclitaxe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Nausea and Vomiting Caused by Chemotherapy | Phase 2 | Status: RECRUITING